Kelun-Biotech receives trial notice for dual-payload ADC
July 28, 2026 | 15:16
Kelun-Biotech, listed under stock code 6990.HK, received a clinical trial notice from China's Center for Drug Evaluation for SKB565, its first dual-payload antibody-drug conjugate.
Mobile Version